Cipla shares surge over 6 percent after Q1 earnings Ruby Khatun Khatun17 Aug 2017 11:59 AM ISTNew Delhi: Shares of drug major Cipla rose over 6 per cent after the company reported 23.63 per cent rise in consolidated net profit for the first...
Zydus Cadila gets USFDA nod for blood pressure drug Ruby Khatun Khatun17 Aug 2017 11:58 AM ISTNew Delhi: Cadila Healthcare on Wednesday said its group firm Zydus Cadila has received final approval from the US health regulator to market blood...
Zydus settles patent case over Aptalis drug Canasa Ruby Khatun Khatun16 Aug 2017 11:00 AM ISTNew Delhi: Zydus group firm Cadila Healthcare on Monday said patent litigation relating to Aptalis' drug Canasa used for treatment of ulcerative...
India aims to revamp health scheme by lowering cost Ruby Khatun Khatun16 Aug 2017 10:30 AM ISTNew Delhi: India's health ministry has trimmed its cost estimates for extending its main public health programme by 25 percent after criticism from a...
Far-right clashes: Merck CEO quits Trump panel Ruby Khatun Khatun16 Aug 2017 10:00 AM ISTCHARLOTTESVILLE: US President Donald Trump faced renewed pressure on Monday to respond more forcefully to a violent white-nationalist rally in...
Chinas Fosun, Shanghai Pharma say bid for stake in US drugmaker Arbor Ruby Khatun Khatun16 Aug 2017 9:30 AM ISTHONG KONG: A unit of China's Fosun Group and Shanghai Pharmaceuticals Holding Co are among bidders for a stake in U.S. speciality drugmaker Arbor...
Sanofi Files Suit in the US to Defend its Patent Rights on Lantus Ruby Khatun Khatun15 Aug 2017 10:30 AM ISTParis, France: Sanofi announced that it filed a patent infringement suit against Merck Sharp & Dohme Corp. (“Merck”) on August 8, 2017 in the...
Gilead announces USFDA Priority Review Designation for FDC of Bictegravir, Emtricitabine, Tenofovir Alafenamide to treat HIV Ruby Khatun Khatun15 Aug 2017 10:15 AM ISTFOSTER CITY, Calif: Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted priority review for the company’s New...
Non Introduction of New Oncology Medicines- Anupriya Patel Ruby Khatun Khatun15 Aug 2017 9:55 AM ISTFifteen anticancer drugs have been approved by the Central Licensing Authority i.e. the Drugs Controller General (India) for import/manufacture and...
Boehringer Ingelheim achieves good growth in the first half of 2017 Ruby Khatun Khatun15 Aug 2017 9:45 AM ISTIngelheim, Germany: Boehringer Ingelheim has delivered positive results for the first half of 2017. Net sales increased by 24 per cent on the same...
Alkem Labs to tap domestic, international markets for growth Ruby Khatun Khatun14 Aug 2017 11:51 AM ISTNew Delhi: Drug firm Alkem Laboratories is looking to tap domestic as well as international markets for growth going forward, the company has said.In...
FDA advisory committee votes in favor of tofacitinib citrate for the treatment of active psoriatic arthritis Ruby Khatun Khatun14 Aug 2017 10:15 AM ISTNEW YORK: Pfizer Inc. announced that the United States Food and Drug Administration’s (FDA) Arthritis Advisory Committee (AAC) voted 10 to 1 to...
